(Received for publication, December 16, 1996, and in revised form, February 27, 1997)
From the Department of Pathology, Brigham and
Women's Hospital and Harvard Medical School, Boston, Massachusetts
02115, the § Department of Physical and Structural
Chemistry, SmithKline Beecham Pharmaceuticals, King of Prussia,
Pennsylvania 19406, and ¶ Onyx Pharmaceuticals,
Richmond, California 94806
Calmodulin regulates numerous fundamental metabolic pathways by binding to and modulating diverse target proteins. In this study, calmodulin-binding proteins were isolated from normal (Hs578Bst) and malignant (MCF-7) human breast cell lines with calmodulin-Sepharose and analyzed by SDS-polyacrylamide gel electrophoresis. A protein that migrated at approximately 190 kDa bound to calmodulin in the presence of Ca2+ and was the only calmodulin-binding protein detected in the absence of Ca2+. This 190-kDa protein was identified as IQGAP1 by nanoelectrospray mass spectrometry and collision-induced dissociation tandem mass spectrometry. IQGAP1 coimmunoprecipitated with calmodulin from lysates of MCF-7 cells. Moreover, overlay with 125I-calmodulin confirmed that IQGAP1 binds directly to calmodulin. Analysis of the functional effects of the interaction revealed that Ca2+/calmodulin disrupted the binding of purified IQGAP1 to the Ras-related protein Cdc42 in a concentration-dependent manner. These data clearly identify IQGAP1 as the predominant calmodulin-binding protein in Ca2+-free breast cell lysates and reveal that calmodulin modulates the interaction between IQGAP1 and Cdc42.
Calmodulin is an acidic effector protein that regulates multiple
processes in eukaryotic cells (1). Upon binding Ca2+, the
conformation of calmodulin is altered (2), exposing hydrophobic residues that mediate its interaction with amphiphilic -helical regions of target proteins (1). Removal of Ca2+ reverses
binding (1). By this mechanism, Ca2+/calmodulin modulates
the activity of several proteins, thereby regulating cellular
metabolism including protein phosphorylation, cell cycle progression,
DNA synthesis, transcription, and cytoskeletal organization (1).
More recently, a novel interaction of calmodulin with a variety of unconventional myosins (3), neuromodulin (4), neurogranin (5), Ras-GRF (6), and IRS-1 (7) was identified. Each of these proteins contains one or more IQ motifs, a sequence of approximately 23 amino acid residues with a consensus IQXXXRGXXXR (8). The presence of the distal arginine in the IQ consensus motif dictates the Ca2+ requirement for binding calmodulin (9). When the arginine residue is present, the IQ motif is said to be complete and Ca2+ is not necessary for calmodulin binding. An incomplete IQ motif does not contain the distal arginine residue, and calmodulin requires Ca2+ to bind the motif (9).
The gene encoding an IQ motif-containing protein was recently cloned from human osteosarcoma tissue by RNA polymerase chain reaction (10). Designated IQGAP1, the predicted protein has a calculated molecular mass of approximately 189 kDa, and contains four complete IQ motifs as well as a region with considerable sequence similarity to the catalytic domain of Ras-GAP1 (10). Since the original submission of this manuscript, three studies have been published that focus on the interaction between IQGAP1 and the Ras-like proteins, Cdc42 and Rac (11-13). However, when isolated as a Cdc42-binding protein from rabbit liver (12), the amino acid sequence of an internal peptide of the 180-kDa protein was not identical to the previously published sequence of IQGAP1 (10). In addition, an antibody to IQGAP1 failed to recognize this putative IQGAP1 from rabbit liver, and the authors proposed that the 180-kDa protein may represent an IQGAP1 homologue (12). Furthermore, the published studies used recombinant IQGAP1 to examine its effect on Ras activity, which produced somewhat conflicting data (10, 11, 13). It is possible that endogenous IQGAP1 undergoes post-translational modification(s) that are not present in the recombinant protein. Therefore experimentation with purified endogenous IQGAP1 is necessary to resolve these discrepancies.
The presence of IQ motifs in IQGAP1 suggests that it binds to calmodulin. In support of this, it was shown very recently that calmodulin associates with the N-terminal region of IQGAP1, which contains the IQ motifs (11, 13). However, the interaction of calmodulin and IQGAP1 has not been characterized and no analysis of the potential functional sequelae has been performed. Here we use calmodulin affinity chromatography to purify sufficient full-length endogenous IQGAP1 from mammalian cells to perform functional analysis. We demonstrate by nanoelectrospray tandem mass spectrometry that calmodulin binds to IQGAP1 in human breast cell lines both in the presence and absence of Ca2+, and we document that calmodulin modulates the interaction between IQGAP1 and Cdc42.
The antibodies to calmodulin (14) and IQGAP1 (11) were described previously. Production of the glutathione S-transferase-Cdc42 fusion protein has been described (11). MCF-7 cells were a gift from Dr. A. Dutta (Brigham and Women's Hospital, Boston, MA). Hs578Bst cells were from the American Type Culture Collection. Calmodulin-Sepharose was purchased from Pharmacia Biotech Inc. Affi-Gel was from Bio-Rad. Tissue culture reagents were obtained from Life Technologies, Inc. Fetal bovine serum was from Biowhitaker. All other reagents were of standard analytical grade.
Cell Culture and LysisMCF-7 and Hs578Bst cells were grown
in Dulbecco's modified Eagle's medium supplemented with 10% (v/v)
fetal bovine serum in a 37 °C humidified incubator. Cells were
washed three times in serum-free medium and lysed in buffer A (50 mM Tris, pH 7.4, 150 mM NaCl, and 1% (v/v)
Triton X-100) with either 1 mM CaCl2 or 1 mM EGTA, and quick-frozen in methanol at 70 °C.
Cell lysates were thawed and immediately subjected to centrifugation at 15,000 × g for 5 min at 4 °C to remove insoluble material. Forty microliters of a 1:1 slurry of calmodulin-Sepharose in 50 mM Tris, pH 7.4, was added to equal amounts of protein lysate and incubated for 3 h at 4 °C while rotating. The calmodulin-Sepharose was washed four times in buffer A with either 1 mM CaCl2 or 1 mM EGTA and resuspended in SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer. Proteins were resolved by SDS-PAGE and either visualized by Coomassie Blue staining or transferred to a polyvinylidene difluoride membrane (PVDF).
Protein DigestionThe procedure for digestion of proteins in polyacrylamide gels was modified from Rosenfeld et al. (16). Briefly, the 190-kDa band was excised from the gel, equilibrated in 100 mM NH4HCO3, reduced, and alkylated with dithiothreitol and iodoacetamide. The gel slice was then washed in 50% (v/v) acetonitrile, 100 mM NH4HCO3, cut into small pieces, and lyophilized. Modified trypsin in 50 mM NH4HCO3 was added, and the sample was incubated overnight at 37 °C. Peptides were extracted twice with 0.1% (v/v) trifluoroacetic acid in 60% (v/v) acetonitrile using sonication, lyophilized, and reconstituted in 5% (v/v) formic acid.
The digest was desalted and concentrated on Poros RII resin (40-60-µm particles, Perseptive Biosystems), which had been packed into an Eppendorf Geloader pipette tip (Brinkman Instruments, Westbury, NY), eluted with 1.5 µl of 5% (v/v) formic acid in 70% (v/v) methanol, and loaded into the back of the nanospray needle.
Protein IdentificationElectrospray mass spectra were acquired on a modified Perkin-Elmer Sciex API-III triple quadrupole tandem mass spectrometer (Thornhill, Ontario, Canada). This instrument is equipped with a high pressure collision cell (PE-Sciex) and an articulated nanospray interface developed by Wilm and Mann (17), and was built at the European Molecular Biology Laboratory in Heidelberg, Germany. The operation of the API-III in the nanospray mode has been described in detail elsewhere (18, 19).
The molecular weights and precursor ion masses for the tryptic peptides in the unfractionated digest were determined by scanning the first quadrupole (Q1) from m/z 400-1500 in 0.1-Da steps using a dwell time of 8 ms/mass step. The resolution was adjusted to determine the isotopes of a triply charged ion up to m/z 1000. This allowed singly, doubly, and triply charged ions to be distinguished from one another.
Selected precursor ions were caused to undergo collision-induced dissociation (CID) in the second quadrupole (Q2). The resulting CID product ions were mass analyzed by scanning the third quadrupole (Q3) using a mass step of 1 Da and a mass defect of 50 millimass units/100 Da. The mass spectrometer was scanned over the desired mass range using a dwell of 20 ms/mass step. This approach produces analytically useful tandem mass spectrometry (MS/MS) data rapidly, allowing many product ion spectra to be acquired with a single loading of sample. Product ion spectra were interpreted manually. Mass spectrometric based sequence tags (20) were searched against a nonredundant protein data base maintained by SmithKline Beecham, using the Peptide Search Program written by Mann and Wilm (20). Peptide fragment ion nomenclature is based on Roepstorff as modified by Biemann (21).
Purification of IQGAP1IQGAP1 was isolated from MCF-7 cells by calmodulin-Sepharose chromatography in buffer A containing 1 mM EGTA as described above. The calmodulin-Sepharose was washed four times in buffer A containing 1 mM EGTA. The IQGAP1 was eluted, dialyzed against phosphate-buffered saline, and concentrated in Centricon concentrators (Amicon).
Immunoprecipitation and ImmunoblottingMCF-7 cell lysates were immunoprecipitated with anti-calmodulin monoclonal antibody linked to Affi-Gel in buffer A containing 1 mM CaCl2 as described (15). Samples were washed five times in lysis buffer, resolved by SDS-PAGE, and transferred to PVDF, and immunoblots were probed with anti-IQGAP1 antibody. Complexes were visualized with horseradish peroxidase-conjugated secondary antibody and developed by enhanced chemiluminescence (ECL).
125I-Calmodulin OverlayAfter protein transfer, the PVDF membrane was blocked in buffer B (50 mM Tris, pH 7.8, 200 mM NaCl, and 0.05% (v/v) Tween 20), supplemented with 1 mM CaCl2 or 1 mM EGTA containing 5% nonfat dry milk. After washing in buffer B, 4 µCi of 125I-calmodulin was added and the blot was incubated for 2 h at 22 °C. The membrane was washed five times in buffer B, dried, and exposed to x-ray film. As a positive control, 0.5 µg of purified calcineurin was processed in parallel.
In Vitro Binding AssayGlutathione S-transferase
(GST) linked to Cdc42 (GST-Cdc42) was treated with 1 mM
EDTA for 10 min to remove bound guanine nucleotides, and then incubated
with 75 µM GDP or GTPS in 5 mM MgCl2 for 30 min to reload. Purified IQGAP1 was incubated
with 1 µg of GST-GTP
S, GST-Cdc42-GDP, or GST-Cdc42-GTP
S in
buffer A containing different concentrations of CaCl2 as
indicated in the figure legends for 30 min at 22 °C. Where
indicated, calmodulin was included in the assay. Complexes were
isolated with glutathione-Sepharose for 30 min at 22 °C while
rotating, resolved by SDS-PAGE, and transferred to PVDF membrane. Blots
were cut in half and the appropriate pieces were probed with
anti-calmodulin or anti-IQGAP1 antibodies. Antigen-antibody complexes
were visualized with horseradish peroxidase-conjugated secondary
antibody developed by ECL.
Protein determinations of the cells lysates were performed using the DC Protein Assay from Bio-Rad. Densitometry of the protein bands on the gels, the ECL signals, and autoradiographs was performed with NIH Image.
Calmodulin-binding proteins were isolated from a normal human
breast cell line, Hs578Bst, and a malignant human breast cell line,
MCF-7, with calmodulin-Sepharose in the presence and absence of
Ca2+, resolved by SDS-PAGE, and stained with Coomassie
Blue. Each lane on the polyacrylamide gel represents the
calmodulin-binding proteins isolated from cell lysate prepared from a
single 100-mm tissue culture dish (approximately 2 × 106 cells). The vast majority of the proteins bound to
calmodulin-Sepharose in a Ca2+-dependent manner
and were dissociated from calmodulin when EGTA was added to the lysate
(Fig. 1). However, one protein with a molecular mass of
approximately 190 kDa bound calmodulin both in the presence and absence
of Ca2+. In both cell lines the amount of the 190-kDa
protein detected in the presence of Ca2+ was 2-fold more
than in the absence of Ca2+. The 190-kDa band was not
dissociated from calmodulin-Sepharose by buffer containing 1 M NaCl and 1% Triton X-100 (data not shown), indicating
high affinity binding. Compared with normal cells, the majority of
calmodulin-binding proteins were present at higher levels in tumor
cells (Fig. 1). By contrast, half as much of the 190-kDa protein from
malignant cells bound to calmodulin. Three unidentified bands of
approximately 47, 55, and 65 kDa were present in all lanes, even when
lysates were incubated with glutathione-Sepharose, suggesting that they
bind nonspecifically to the Sepharose beads (Fig. 1).
To identify the 190-kDa protein, the Coomassie Blue-stained band from
one lane (MCF-7, Ca2+) was digested in situ
with trypsin and analyzed by electrospray mass spectrometry using a
nanoliter flow interface (17). The nanospray source introduces samples
into the mass spectrometer at flow rates on the order of 25-40 nl/min,
thus allowing up to 40 min of data collection time for a single 1-µl
loading of sample. These long sampling periods allow ample time for
multiple experiments in which analysis parameters are optimized, and
spectra can be accumulated to obtain useful data even from very weak
signals. However, all electrospray methods are sensitive to the type
and concentration of salts and buffers present in the sample. In
addition, because signal response in an electrospray ion source is
concentration-dependent, it is beneficial to have the
sample in the smallest possible volume. For nanospray, this is ideally
1-2 µl. Therefore, to desalt and concentrate unfractionated in-gel
protein digests, we have developed a simple method that uses gel
loading pipette tips packed with a 3-4-mm height bed of reverse phase
chromatographic material (22). After washing away the salts and
buffers, the peptides can be eluted with 1.5 µl of solvent. This
preparation step is critical to the success of the nanospray
experiment. Typically, the entire sample is loaded into the nanospray
needle. A similar sample preparation approach has been described by
Wilm and co-workers (23).
The identity of a protein present in a proteolyzed gel slice can be determined using the sequence tag approach of Mann and Wilm (20). Briefly, an electrospray ionization mass spectrum of the entire mixture is recorded and, based on these data, peptide precursor ions are chosen to be sequenced by CID MS/MS in the triple quadrupole mass spectrometer. Partial sequences as short as 2-3 amino acids can then be used to identify proteins in a data base by the inclusion in the search of the peptide molecular weight and the masses of the portions of the peptide that precede and follow the determined partial sequence.
The mass spectrum of the unfractionated digest of the 190-kDa band
exhibited a broad distribution of peptide molecular ions with charge
states varying from 1+ to 4+ (Fig.
2A). Initially, a doubly charged ion at
m/z 617.3 was selected for CID MS/MS. The product ion
spectrum of this peptide is shown in Fig. 2B. From these
data, the partial sequence, PDA, was derived. Using the approach
outlined above, together with the enzyme specificity of trypsin as a
limiter, a search was made of an in-house nonredundant protein data
base modified for the program Peptide Search (20). A single peptide
sequence, FPDAGEDELLK (Mr = 1232.6), from IQGAP1 (10) was matched (Table I). Other major ions in the CID
spectrum could now be assigned as bn and
yn fragments that are predicted to be formed based
on the indicated sequence. In this manner, confidence is gained that
the correct sequence has been identified. During the analysis of the
CID spectrum from m/z 617.3 precursor, a second IQGAP1
sequence was discovered, which could be assigned to the peptide,
YQELINDIAR (Mr 1233.6). The doubly charged ion
for this peptide [M + 2H]2+ = 617.8 would overlap the
13C peak of the first peptide, and so be included in the
precursor ion selection window (which has a width of approximately 3 Da). Ions belonging to this second sequence are indicated by in
Fig. 2, but are not otherwise labeled for the sake of clarity. Two additional doubly charged precursors from the unfractionated digest were sequenced by CID MS/MS and sequence tags from their spectra also
matched tryptic peptides from IQGAP1 (Table I). Moreover, 18 other
peptide ions matched tryptic peptides from IQGAP1 based on molecular
weight alone (Table I). These data establish that the 190-kDa
calmodulin-binding protein is IQGAP1.
|
The mass spectrometry-based analytical approaches used in the present study for identifying proteins from gels are both sensitive and fast. After enzymatic digestion and desalting of the peptides, identification of the 190-kDa protein as IQGAP1 using data base searching of mass spectrometrically derived partial amino acid sequences took approximately 20 min. Forty percent of the sample was used to record the molecular weights of the tryptic peptides and sequence the three precursor ions. The remaining 60% of the digest was stored frozen in the nanospray needle in the event further characterization (such as characterizing suspected post-translational modifications) was necessary.
Additional verification that the 190-kDa band was IQGAP1 was obtained
by transferring to PVDF proteins that bound to calmodulin-Sepharose and
probing the membrane with anti-IQGAP1 antibody. A single band migrating
at 190 kDa was detected (Fig. 3A), confirming
its identity as IQGAP1. Analogous to the results obtained in the
Coomassie Blue-stained gels (see Fig. 1), 2-fold more IQGAP1 bound
calmodulin when Ca2+ was included in the incubation buffer
(Fig. 3A). Previous studies with immunoprecipitation of
lysates from 3T3 cells with anti-IQGAP1 antibody revealed calmodulin,
demonstrating that IQGAP1 and calmodulin form a complex in
vivo (11). We performed the reverse experiment. Endogenous
calmodulin was isolated with anti-calmodulin antibody, and immunoblots
were probed with anti-IQGAP1 antibody. A single band migrating at 190 kDa was detected (Fig. 3B), indicating that the interaction
occurs in MCF-7 cells.
It is possible that IQGAP1 binds in a complex and does not associate
directly with calmodulin. To resolve this issue,
125I-calmodulin overlay was performed after proteins were
isolated from MCF-7 cells by calmodulin-Sepharose and transferred to
PVDF. 125I-calmodulin binding was evaluated both in the
presence and absence of Ca2+. When the overlay was
performed in the presence of Ca2+, at least seven proteins
were identified that bound to Ca2+/calmodulin-Sepharose
(Fig. 4A, lane 1). In contrast,
only two 125I-calmodulin-binding proteins associated with
Ca2+-free-calmodulin-Sepharose (Fig. 4A,
lane 2). As predicted from the Coomassie Blue-stained gel in
Fig. 1, IQGAP1 was detected by 125I-calmodulin in samples
incubated with Ca2+-containing or Ca2+-free
calmodulin-Sepharose (Fig. 4A, lanes 1 and
2). In addition, an unidentified protein that migrated on
SDS-PAGE slightly further than IQGAP1 bound 125I-calmodulin
only when lysates were incubated with Ca2+-free
calmodulin-Sepharose (Fig. 4A, lane 2). It is
possible that this band is IQGAP2, which migrates at 175 kDa on
SDS-PAGE (12). Purified calcineurin, a well characterized
Ca2+-dependent calmodulin-binding protein (24),
was used as a positive control. 125I-Calmodulin bound to
calcineurin when the overlay was performed in the presence of
Ca2+ (Fig. 4A, lane 3), but not in
its absence (Fig. 4B, lane 3). Although IQGAP1
bound to calmodulin-Sepharose both in the presence and absence of
Ca2+, 125I-calmodulin did not bind IQGAP1
appreciably when the overlay buffer contained EGTA (Fig. 4B,
lanes 1 and 2). Although not visible in Fig.
4B, a longer exposure of the autoradiograph revealed IQGAP1 when the overlay buffer lacked Ca2+ (data not shown). While
the IQ motifs of some proteins bind calmodulin in the presence of
Ca2+, others have higher affinity when Ca2+ is
absent (3). For example, rat myr 4 has two IQ motifs; one binds
Ca2+/calmodulin, and the other binds Ca2+-free
calmodulin (25). IQGAP1 has four IQ motifs (10), and the
Ca2+ dependence for calmodulin binding to individual IQ
motifs is unknown. Therefore, it is possible that some of the IQ motifs in IQGAP1 are unable to bind calmodulin in the overlay procedure. This
result is not surprising, since approximately 50% of
calmodulin-binding proteins are not detected by the overlay method
(26). Note also that none of the other proteins that bound to
Ca2+-free calmodulin-Sepharose (Fig. 4A,
lane 2) was detected by 125I-calmodulin in the
absence of Ca2+ (Fig. 4B).
After the original submission of this manuscript, it was shown that
IQGAP1 in cell lysates and in vitro translated IQGAP1 associate with the activated form of GST-Cdc42 (11-13). Similarly, we
isolated IQGAP1 from MCF-7 cell lysates with GST-Cdc42 but not with GST
alone (data not shown). To extend these findings, we examined the
effect of calmodulin on the interaction between IQGAP1 and Cdc42.
Full-length purified human IQGAP1 was incubated with either GST
preloaded with GTPS (GST-GTP
S), or GST-Cdc42 loaded with GDP
(GST-Cdc42-GDP) or GTP
S (GST-Cdc42-GTP
S), and complexes were
isolated with glutathione-Sepharose. IQGAP1 was present only in samples
containing GST-Cdc42-GTP
S (Fig. 5A), confirming previous observations that purified IQGAP1 bound to the
activated form of GST-Cdc42 (11, 13). Binding was specific as minimal
IQGAP1 was detected in the samples incubated with GST-GTP
S. Preincubation of IQGAP1 with calmodulin prior to the addition of Cdc42
to the assay disrupted the interaction between IQGAP1 and Cdc42 (Fig.
5, A and B). In contrast, calmodulin was unable to displace IQGAP1 that was already bound to Cdc42 (Fig.
5B).
The inhibition of the binding of IQGAP1 to Cdc42 by calmodulin was
characterized. The extent of disruption of the IQGAP1·GST-Cdc42 complex was proportional to the concentration of calmodulin added. With
approximately 4 nM IQGAP1 in the assay, calmodulin
concentrations of 10 nM or greater completely prevented
binding, while 2 nM calmodulin had no effect (Fig.
6A). Furthermore, the
calmodulin-dependent modulation of IQGAP1 binding to Cdc42
was regulated by Ca2+. In the absence of added
Ca2+, calmodulin did not interfere with the association of
IQGAP1 with Cdc42 (Fig. 6B). In the presence of calmodulin,
Ca2+ produced a dose-dependent inhibition of
binding of IQGAP1 to Cdc42 (Fig. 6B). The effect of
Ca2+ was mediated via calmodulin as addition of
Ca2+ alone (without calmodulin) did not impair the binding
of IQGAP1 to Cdc42 (Fig. 6B). These data indicate that
Ca2+/calmodulin prevents the binding of IQGAP1 to Cdc42,
while Ca2+-free calmodulin does not. In all cases, minimal
IQGAP1 bound to GST alone (data not shown). No calmodulin was detected
on the blots (data not shown), confirming that, as observed previously (11), calmodulin does not associate directly with Cdc42. Cdc42 binds to
the Ras-GAP-related domain in the C-terminal region of IQGAP1 (residues
915-1657) (11), while calmodulin binds to the N terminus (11), which
contains the IQ motifs. Therefore, the effect of calmodulin on the
interaction between Cdc42 and IQGAP1 is probably not direct competition
for binding, but is more likely due to a
Ca2+/calmodulin-induced alteration in the conformation of
IQGAP1.
The binding of calmodulin to IQ motifs results in diverse effects on the target proteins. For example, Ca2+/calmodulin promotes the binding of Ras-GRF to Ras thereby activating GTPase activity (6). In contrast, while binding of calmodulin typically activates target proteins, the interaction of calmodulin with the IQ motif of p68 RNA helicase decreases enzyme activity (27). We observed a novel effect, where the binding of Ca2+/calmodulin, but not Ca2+-free calmodulin, prevented the association of IQGAP1 with Cdc42. Since IQGAP1 alters the GTPase activity of Cdc42 (11), our data suggest that Ca2+/calmodulin regulates Cdc42 by modulating its interaction with IQGAP1. This may occur in intact cells as the effects were observed at physiological concentrations of Ca2+ and calmodulin. In support of this hypothesis, it has been shown that sustained elevation of intracellular Ca2+ dissociates Cdc42 from the cytoskeleton of activated platelets (28). The authors also demonstrated that chelation of Ca2+ with BAPTA-AM preserved the interaction of Cdc42 with the cytoskeleton, but the role of calmodulin was not evaluated (28).
IQGAP1 contains four putative IQ motifs (10), and the Ca2+ requirement for calmodulin binding to individual IQ motifs is not known. It has been reported recently that calmodulin binding to some IQ motifs requires Ca2+, while binding to other IQ motifs occurs in the absence of Ca2+ (29). The Ca2+ dependence of the interaction of calmodulin with individual IQ motifs depends on the amino acid sequence of the motif, the number of molecules of calmodulin bound to the protein if multiple IQ motifs are present, and the sequence in which IQ motifs become occupied with calmodulin molecules (29). Calmodulin binds to IQGAP1 both in the presence and absence of Ca2+, but inhibits the association between IQGAP1 and Cdc42 only in the presence of Ca2+ (Figs. 5 and 6). These data are consistent with the model of Houdusse et al. (29) and suggest that occupation of all the calmodulin binding sites in IQGAP1 is not necessary to disrupt its interaction with Cdc42. Mutagenesis studies are in progress to identify the critical region(s) required to mediate this inhibitory effect.
Based on its sequence similarity to GAP (10), IQGAP1 was predicted to act as a Ras-GAP. Recently, however, it was shown that recombinant IQGAP1 does not bind Ras, but binds Cdc42, and maintains it in the GTP-bound state (11). Since GTP hydrolysis is necessary to deactivate Ras family proteins (30), IQGAP1 has been hypothesized to function in cell transformation induced by Ras-like proteins (10). Cdc42 participates in cell cycle progression (31) and, with other Ras-related proteins (including Rac and Rho), influences cytoskeletal assembly (32). Both cell cycle progression (33) and cytoskeletal assembly (34) are also modulated by calmodulin. Furthermore, overexpression of calmodulin shortened the cell cycle and altered cell morphology (35). A recent study illustrated that Cdc42 is localized primarily in the Golgi apparatus in mammalian cells, where it may play a role in vesicular transport (36). Similarly, calmodulin has been linked to vesicular transport and calmodulin antagonists interfere with Golgi function (37). Despite these overlapping functions, the role of calmodulin in signaling pathways involving Cdc42 has not been investigated.
Calmodulin levels are significantly increased in malignant cells (38), including breast cancer (39). In concordance with these observations, we observed that calmodulin levels were increased by 2-fold in MCF-7 cells as compared with normal breast cells.2 It is not known whether the increased calmodulin contributes to neoplastic transformation or is a consequence of the altered cellular homeostasis that occurs during malignancy. Since calmodulin regulates the interaction of IQGAP1 with Cdc42, and Cdc42 participates in cell proliferation, differentiation, and morphology, it is possible that increased levels of calmodulin contribute to breast carcinogenesis by modulating the activity of Cdc42. Understanding the molecular mechanisms by which normal cells become malignant could potentially contribute to improved methods of prevention, detection and treatment of cancer. Therefore, future studies should be directed toward examining the interactions among calmodulin, IQGAP1, and Cdc42 in malignant transformation.
We thank Zhigang Li for expert technical assistance and Sharon Porter (Washington University Medical Center, St. Louis, MO) for preparing the anti-calmodulin antibody.